Takeda colitis drug raises PML concern: FDA staff
(Reuters) - An experimental drug for ulcerative colitis and Crohn's disease from Takeda Pharmaceutical Co could pose risk of a potentially fatal brain...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MppAt00OgXY/story01.htm
No comments:
Post a Comment